Literature DB >> 18523230

The p110gamma isoform of phosphatidylinositol 3-kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites.

Molly S Thomas1, Jason S Mitchell, Christopher C DeNucci, Amanda L Martin, Yoji Shimizu.   

Abstract

The role of PI-3K in leukocyte function has been studied extensively. However, the specific role of the p110gamma isoform of PI- 3K in CD4 T lymphocyte function has yet to be defined explicitly. In this study, we report that although p110gamma does not regulate antigen-dependent CD4 T cell activation and proliferation, it plays a crucial role in regulating CD4 effector T cell migration. Naïve p110gamma(-/-) CD4 lymphocytes are phenotypically identical to their wild-type (WT) counterparts and do not exhibit any defects in TCR-mediated calcium mobilization or Erk activation. In addition, p110gamma-deficient CD4 OT.II T cells become activated and proliferate comparably with WT cells in response to antigen in vivo. Interestingly, however, antigen-experienced, p110gamma-deficient CD4 OT.II lymphocytes exhibit dramatic defects in their ability to traffic to peripheral inflammatory sites in vivo. Although antigen-activated, p110gamma-deficient CD4 T cells express P-selectin ligand, beta2 integrin, beta1 integrin, CCR4, CXCR5, and CCR7 comparably with WT cells, they exhibit impaired F-actin polarization and migration in response to stimulation ex vivo with the CCR4 ligand CCL22. These findings suggest that p110gamma regulates the migration of antigen-experienced effector CD4 T lymphocytes into inflammatory sites during adaptive immune responses in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18523230      PMCID: PMC2516906          DOI: 10.1189/jlb.0807561

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  48 in total

1.  The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells.

Authors:  J J Campbell; G Haraldsen; J Pan; J Rottman; S Qin; P Ponath; D P Andrew; R Warnke; N Ruffing; N Kassam; L Wu; E C Butcher
Journal:  Nature       Date:  1999-08-19       Impact factor: 49.962

2.  Microenvironment-dependent requirement of STAT4 for the induction of P-selectin ligands and effector cytokines on CD4+ T cells in healthy and parasite-infected mice.

Authors:  Uta Syrbe; Ute Hoffmann; Kerstin Schlawe; Oliver Liesenfeld; Klaus Erb; Alf Hamann
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

Review 3.  T lymphocytes on the move: chemokines, PI 3-kinase and beyond.

Authors:  Stephen G Ward
Journal:  Trends Immunol       Date:  2006-01-18       Impact factor: 16.687

4.  Effective attenuation of acute lung injury in vivo and the formyl peptide-induced neutrophil activation in vitro by CYL-26z through the phosphoinositide 3-kinase gamma pathway.

Authors:  Yu-Hsiang Kuan; Ruey-Hseng Lin; Yeh-Long Chen; Lo-Ti Tsao; Cherng-Chyi Tzeng; Jih-Pyang Wang
Journal:  Biochem Pharmacol       Date:  2006-08-02       Impact factor: 5.858

5.  Leukocyte phosphoinositide-3 kinase {gamma} is required for chemokine-induced, sustained adhesion under flow in vivo.

Authors:  David F Smith; Tracy L Deem; Anthony C Bruce; Jörg Reutershan; Daniel Wu; Klaus Ley
Journal:  J Leukoc Biol       Date:  2006-09-22       Impact factor: 4.962

6.  Involvement of phosphoinositide 3-kinase gamma, Rac, and PAK signaling in chemokine-induced macrophage migration.

Authors:  Cornelia Weiss-Haljiti; Christian Pasquali; Hong Ji; Corine Gillieron; Christian Chabert; Marie-Laure Curchod; Emilio Hirsch; Anne J Ridley; Rob Hooft van Huijsduijnen; Montserrat Camps; Christian Rommel
Journal:  J Biol Chem       Date:  2004-07-29       Impact factor: 5.157

7.  Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing.

Authors:  César Nombela-Arrieta; Rosa Ana Lacalle; María C Montoya; Yuya Kunisaki; Diego Megías; Miriam Marqués; Ana C Carrera; Santos Mañes; Yoshinori Fukui; Carlos Martínez-A; Jens V Stein
Journal:  Immunity       Date:  2004-09       Impact factor: 31.745

8.  The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells.

Authors:  Klaus Okkenhaug; Daniel T Patton; Antonio Bilancio; Fabien Garçon; Wendy C Rowan; Bart Vanhaesebroeck
Journal:  J Immunol       Date:  2006-10-15       Impact factor: 5.422

9.  In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines.

Authors:  K M Ansel; L J McHeyzer-Williams; V N Ngo; M G McHeyzer-Williams; J G Cyster
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

10.  Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers.

Authors:  L S Walker; A Gulbranson-Judge; S Flynn; T Brocker; C Raykundalia; M Goodall; R Förster; M Lipp; P Lane
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

View more
  27 in total

Review 1.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

Authors:  Lomon So; David A Fruman
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

Review 2.  PI3Kδ-selective and PI3Kα/δ-combinatorial inhibitors in clinical development for B-cell non-Hodgkin lymphoma.

Authors:  Benjamin L Lampson; Jennifer R Brown
Journal:  Expert Opin Investig Drugs       Date:  2017-10-06       Impact factor: 6.206

Review 3.  Exploring a Future for PI3K Inhibitors in Chronic Lymphocytic Leukemia.

Authors:  Krish Patel; John M Pagel
Journal:  Curr Hematol Malig Rep       Date:  2019-08       Impact factor: 3.952

4.  Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM).

Authors:  Hannah Carter; Josue Samayoa; Ralph H Hruban; Rachel Karchin
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

Review 5.  PI3Ks in lymphocyte signaling and development.

Authors:  Klaus Okkenhaug; David A Fruman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 6.  Lipid signaling in T-cell development and function.

Authors:  Yina H Huang; Karsten Sauer
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-10-13       Impact factor: 10.005

7.  Phosphoinositide 3-Kinase Gamma Contributes to Neuroinflammation in a Rat Model of Surgical Brain Injury.

Authors:  Lei Huang; Prativa Sherchan; Yuechun Wang; Cesar Reis; Richard L Applegate; Jiping Tang; John H Zhang
Journal:  J Neurosci       Date:  2015-07-22       Impact factor: 6.167

8.  Leukotriene B4 mediates gammadelta T lymphocyte migration in response to diverse stimuli.

Authors:  Maria Fernanda de Souza Costa; Raquel de Souza-Martins; Mariana C de Souza; Cláudia F Benjamim; Bruno Piva; Bruno L Diaz; Marc Peters-Golden; Maria das Graças Henriques; Cláudio Canetti; Carmen Penido
Journal:  J Leukoc Biol       Date:  2009-10-30       Impact factor: 4.962

9.  Pten loss in CD4 T cells enhances their helper function but does not lead to autoimmunity or lymphoma.

Authors:  Dalya R Soond; Fabien Garçon; Daniel T Patton; Julia Rolf; Martin Turner; Cheryl Scudamore; Oliver A Garden; Klaus Okkenhaug
Journal:  J Immunol       Date:  2012-05-18       Impact factor: 5.422

Review 10.  Signaling by the phosphoinositide 3-kinase family in immune cells.

Authors:  Klaus Okkenhaug
Journal:  Annu Rev Immunol       Date:  2013-01-16       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.